Filter Results :

Your search for Immune returned 153 reports

Sort by


Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

01 Apr 2015  |  Published by:  DelveInsight
SummaryDelveInsight’s, Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura)-API Insights, 2015,report provides Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) drugs marketed details and API Manufacturers details across the globe along with the location. The rep...

$ 1,250.00

Read More

Acquired (Autoimmune) Hemolytic Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

01 Apr 2015  |  Published by:  DelveInsight
SummaryDelveInsight’s, Acquired (Autoimmune) Hemolytic Anemia-API Insights, 2015,report provides Acquired (Autoimmune) Hemolytic Anemia drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File...

$ 1,250.00

Read More

Idiopathic Thrombocytopenic Purpura (Immune Thombocytopenic Purpura)-Pipeline Insights, 2015

01 Apr 2015  |  Published by:  DelveInsight
SUMMARYDelveInsight’s, “ Idiopathic Thrombocytopenic Purpura (Immune Thombocytopenic Purpura)-Pipeline Insights, 2015”, report provides comprehensive insights about pipeline drugs across this Idiopathic Thrombocytopenic Purpura (Immune Thombocytopenic Purpura). A key objective of DelveInsight’s rep...

$ 1,250.00

Read More

Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura)-Pipeline Insights, 2015

01 Apr 2015  |  Published by:  DelveInsight
SUMMARYDelveInsight’s, “ Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura)-Pipeline Insights, 2015”, report provides comprehensive insights about pipeline drugs across this Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura). A key objective of DelveInsight’s r...

$ 1,250.00

Read More

Primary Immune Deficiency (PID)-Pipeline Insights, 2015

01 Apr 2015  |  Published by:  DelveInsight
SUMMARYDelveInsight’s, “ Primary Immune Deficiency (PID)-Pipeline Insights, 2015”, report provides comprehensive insights about pipeline drugs across this Primary Immune Deficiency (PID). A key objective of DelveInsight’s report is to establish the understanding for all the pipeline drugs that fall...

$ 1,250.00

Read More

Adimmune Corporation (4142) - Financial and Strategic SWOT Analysis Review

04 Mar 2015  |  Published by:  GlobalData
SummaryAdimmune Corporation (Adimmune) is a pharmaceutical company. The company manufactures products, such as vaccines, diagnostics, and biological products. The company’s vaccine products include Japan encephalitis vaccine, tetanus toxoid adsorbed vaccine, influenza vaccine, and ah1n1 vaccine. It ...

$ 300.00

Read More

TapImmune Inc. (TPIV) - Financial and Strategic SWOT Analysis Review

04 Mar 2015  |  Published by:  GlobalData
SummaryTapImmune Inc. (TapImmune) is a biotechnology company. The company develops peptide and gene-based immunotherapeutics and vaccines for the treatment of oncology and infectious disease. Its immunotherapy technologies are used to prevent emerging viral pathogens for pandemics and biodefense. Ta...

$ 300.00

Read More

Autoimmune Disease Partnering Terms and Agreements

01 Mar 2015  |  Published by:  CurrentPartnering
The Autoimmune Disease Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the autoimmune disease partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in autoimmune disease partnering deals Avera...

$ 2,995.00

Read More

Competitor Analysis: IDO & TDO Inhibitors - Novel Immune Response Checkpoint Modulators

01 Mar 2015  |  Published by:  La Merie Business Intelligence
The Competitive Intelligence report aboutIDO & TDO Inhibitors - Novel Immune Response Checkpoint Modulators provides a competitor analysis as of March 2015 in the development pipeline of novel inhibitors of indoleamine 2,3-dioxygenase (IDO) and tryptophan 2,3- dioxygenase (TDO) for treatme...

$ 162.97

Read More

Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline Review, H1 2015

28 Feb 2015  |  Published by:  Global Markets Direct
Summary‘Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline Review, H1 2015’, provides an overview of the Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura)’s therapeutic pipeline.This report provides comprehensive information on the therapeutic develo...

$ 2,000.00

Read More

Acquired (Autoimmune) Hemolytic Anemia - Pipeline Review, H1 2015

10 Feb 2015  |  Published by:  Global Markets Direct
Summary‘Acquired (Autoimmune) Hemolytic Anemia - Pipeline Review, H1 2015’, provides an overview of the Acquired (Autoimmune) Hemolytic Anemia’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Acquired (Autoimmune) Hemolytic Anemia, complete wit...

$ 2,000.00

Read More

Global Immune Function Agents Industry 2015 Market Research Report

30 Jan 2015  |  Published by:  9Dimen Research
2015 GlobalImmune Function Agents Industry Report is a professional and in-depth research report on the world's major regional market conditions of theImmune Function Agents industry, focusing on the main regions (North America, Europe and Asia) and the main countries (United States, Germany, Japan ...

$ 2,850.00

Read More

Primary Immune Deficiency (PID) - Pipeline Review, H2 2014

31 Dec 2014  |  Published by:  Global Markets Direct
Summary ‘Primary Immune Deficiency (PID) - Pipeline Review, H2 2014’, provides an overview of the Primary Immune Deficiency (PID)’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Primary Immune Deficiency (PID), complete with comparative analys...

$ 2,000.00

Read More

Immune Design Corp. - Product Pipeline Review - 2014

10 Dec 2014  |  Published by:  Global Markets Direct
Summary'Immune Design Corp. - Product Pipeline Review - 2014’, provides an overview of the Immune Design Corp.’s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Immune Design Corp.’s, complete with comp...

$ 1,500.00

Read More

Autoimmune Drugs Markets in China

01 Dec 2014  |  Published by:  Asia Market Info and Dev Co.
China's demand for Autoimmune Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & exp...

$ 4,000.00

Read More
Total 153 records.